TheraVet SA — Board/Management Information 2021

Dec 16, 2021

TheraVet is strengthening its corporate governance with the appointment of three new independent board members

Simon Wheeler is to be co -opted as an independent director and will chair TheraVet ��s Board of Directors

Nesya Goris and Christian Schirvel will also join the board as independent director and independent observer respectively

Gosselies (Wallonia, Belgium), 16 December 2021 �� 7:30 am CET �� TheraVet SN:

381 974 BE0 - ticker: ALVET), nliops iostear culmn a for, i coreng en gvby co ing wne idtr ecos

(Simon Whlr and Nes Goris) and an ipt obs nde v (Chrstan Schirvel). Their hbrds e apoint Cmdi lyht oapr oldxtS ral Mt en g.Smon Whrwi el sorpc Lotfi YsCaouc sCaouc aouc s Chirmnof ThraVtraVt d fDiects.

Lotfi YsCaouc sCaouc aouc s Chirmnof ThraVtraVt s

Enrico Bastianelli, TheraVet ��s CEO, said: ��We are delighted that t hree new independent members of the quality of Simon Wheeler, ,Nesya Goris and Christian Schirvel will be joining our Board of Directors. We are confident that their experience working in both large corporations and smaller companies in the veterinary field, along with their expertise in animal health, will be valuable assets as we pursue our strategic development.

Dr Simon Wheeler , BVSc, PhD, said: "It is an honor to join TheraVet’s Board of Directors. The team has already accomplished great things under the leadership of Enrico Bastianelli and the governance of the Board of Directors, chaired by Lotfi Yelles Chaouche. We are justifiably excited about the future of TheraVet as the Company enters a commercialization phase whi le continuing the clinical development of its veterinary product portfolio. I am confident that the hard work of the TheraVet team will continue to produce fantastic results for pets and their owners, in association with the veterinary professionals who provide them with high quality clinical care."

Dr Nesya Goris , PhD in veterinary sciences , said: �������������������������������������������������������������������������������������� offering in the field of osteoarticular diseases have t he potential to make a significant impact on the quality of life of cats, dogs and horses and it is a pleasure for me to be able to witness and hopefully contribute to this story .��

Dr Christian Schirvel, D VM, MSc, said: ��It is with great pleasure that I am joining TheraVet��s Board of Directors. I have worked in the veterinary pharmaceutical industry for over 30 years and have helped

==> picture [33 x 33] intentionally omitted <==

==> picture [44 x 44] intentionally omitted <==

Page of